Disseminated Intravascular Coagulation
"Disseminated Intravascular Coagulation" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A disorder characterized by procoagulant substances entering the general circulation causing a systemic thrombotic process. The activation of the clotting mechanism may arise from any of a number of disorders. A majority of the patients manifest skin lesions, sometimes leading to PURPURA FULMINANS.
Descriptor ID |
D004211
|
MeSH Number(s) |
C15.378.100.220 C15.378.463.250 C15.378.925.220
|
Concept/Terms |
Disseminated Intravascular Coagulation- Disseminated Intravascular Coagulation
- Disseminated Coagulation, Intravascular
- Coagulation, Intravascular Disseminated
- Coagulations, Intravascular Disseminated
- Disseminated Coagulations, Intravascular
- Intravascular Disseminated Coagulations
- Intravascular Coagulation, Disseminated
- Intravascular Disseminated Coagulation
- Coagulation, Disseminated Intravascular
- Coagulations, Disseminated Intravascular
- Disseminated Intravascular Coagulations
- Intravascular Coagulations, Disseminated
- Consumption Coagulopathy
- Coagulopathies, Consumption
- Coagulopathy, Consumption
- Consumption Coagulopathies
|
Below are MeSH descriptors whose meaning is more general than "Disseminated Intravascular Coagulation".
Below are MeSH descriptors whose meaning is more specific than "Disseminated Intravascular Coagulation".
This graph shows the total number of publications written about "Disseminated Intravascular Coagulation" by people in this website by year, and whether "Disseminated Intravascular Coagulation" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
2000 | 1 | 0 | 1 |
2002 | 0 | 1 | 1 |
2007 | 1 | 0 | 1 |
2008 | 2 | 0 | 2 |
2009 | 2 | 0 | 2 |
2014 | 0 | 1 | 1 |
2015 | 1 | 0 | 1 |
2016 | 1 | 0 | 1 |
2017 | 15 | 5 | 20 |
2018 | 21 | 4 | 25 |
2019 | 12 | 2 | 14 |
2020 | 19 | 23 | 42 |
2021 | 8 | 7 | 15 |
To return to the timeline, click here.
Below are the most recent publications written about "Disseminated Intravascular Coagulation" by people in Profiles.
-
A mild deficiency of ADAMTS13 is associated with severity in COVID-19: comparison of the coagulation profile in critically and noncritically ill patients. Blood Coagul Fibrinolysis. 2021 Oct 01; 32(7):458-467.
-
Mesenchymal stem cell transfusion: Possible beneficial effects in COVID-19 patients. Transfus Apher Sci. 2021 Dec; 60(6):103237.
-
[The Clinical Characteristics and Influencing Factors of Patients with Severe COVID-19]. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2021 Aug; 29(4):1295-1300.
-
Heparanase as a potential player in SARS-CoV-2 infection and induced coagulopathy. Biosci Rep. 2021 07 30; 41(7).
-
Predicted and Observed Incidence of Thromboembolic Events among Koreans Vaccinated with ChAdOx1 nCoV-19 Vaccine. J Korean Med Sci. 2021 Jul 12; 36(27):e197.
-
A macrophage attack culminating in microthromboses characterizes COVID 19 pneumonia. Immun Inflamm Dis. 2021 12; 9(4):1336-1342.
-
COVID-19-related laboratory coagulation findings. Int J Lab Hematol. 2021 Jul; 43 Suppl 1:36-42.
-
COVID-19: Thrombosis, thromboinflammation, and anticoagulation considerations. Int J Lab Hematol. 2021 Jul; 43 Suppl 1:29-35.
-
Vaccine-Induced Immune Thrombotic Thrombocytopenia with Disseminated Intravascular Coagulation and Death following the ChAdOx1 nCoV-19 Vaccine. J Stroke Cerebrovasc Dis. 2021 Sep; 30(9):105938.
-
Antiphospholipid Antibodies and Infection: Non Nova Sed Nove. Front Immunol. 2021; 12:687534.